American International Group, Inc. Agios Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$21.32 - $34.81 $5,010 - $8,180	-235 Reduced 0.85%	27,375 $800,000
Q4 2023 Feb 13, 2024	SELL	$19.97 - $24.53 $2,236 - $2,747	-112 Reduced 0.4%	27,610 $614,000
Q3 2023 Nov 13, 2023	BUY	$24.36 - $28.18 $24,018 - $27,785	986 Added 3.69%	27,722 $686,000
Q2 2023 Aug 04, 2023	BUY	$21.38 - $29.19 $8,466 - $11,559	396 Added 1.5%	26,736 $757,000
Q1 2023 May 12, 2023	BUY	$21.74 - $30.93 $11,413 - $16,238	525 Added 2.03%	26,340 $605,000
Q4 2022 Feb 10, 2023	SELL	$24.81 - $31.52 $2,332 - $2,962	-94 Reduced 0.36%	25,815 $724,000
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $7,121 - $12,461	365 Added 1.43%	25,909 $733,000
Q2 2022 Aug 12, 2022	SELL	$17.06 - $31.42 $24,464 - $45,056	-1,434 Reduced 5.32%	25,544 $566,000
Q1 2022 May 13, 2022	SELL	$26.68 - $34.81 $50,638 - $66,069	-1,898 Reduced 6.57%	26,978 $785,000
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $100,779 - $169,600	-3,407 Reduced 10.55%	28,876 $949,000
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $93,816 - $130,206	-2,238 Reduced 6.48%	32,283 $1.49 Million
Q2 2021 Aug 13, 2021	BUY	$52.06 - $61.27 $1.76 Million - $2.07 Million	33,725 Added 4236.81%	34,521 $1.9 Million
Q1 2021 May 07, 2021	SELL	$44.23 - $57.5 $3,184 - $4,140	-72 Reduced 8.29%	796 $41,000
Q4 2020 Feb 12, 2021	SELL	$33.21 - $46.54 $298 - $418	-9 Reduced 1.03%	868 $38,000
Q3 2020 Nov 04, 2020	SELL	$33.87 - $55.93 $338 - $559	-10 Reduced 1.13%	877 $31,000
Q2 2020 Aug 12, 2020	SELL	$34.45 - $53.48 $4,547 - $7,059	-132 Reduced 12.95%	887 $47,000
Q1 2020 May 04, 2020	BUY	$31.52 - $53.81 $5,263 - $8,986	167 Added 19.6%	1,019 $36,000
Q4 2019 Feb 05, 2020	SELL	$30.08 - $50.59 $872 - $1,467	-29 Reduced 3.29%	852 $41,000
Q2 2019 Aug 13, 2019	SELL	$46.17 - $68.1 $12,927 - $19,068	-280 Reduced 24.12%	881 $44,000
Q1 2019 May 06, 2019	SELL	$45.92 - $67.67 $1,882 - $2,774	-41 Reduced 3.41%	1,161 $78,000
Q3 2018 Nov 09, 2018	SELL	$71.67 - $91.95 $143 - $183	-2 Reduced 0.17%	1,202 $93,000
Q2 2018 Aug 08, 2018	BUY	$73.22 - $99.55 $6,150 - $8,362	84 Added 7.5%	1,204 $101,000
Q1 2018 May 07, 2018	BUY	$59.83 - $86.53 $8,735 - $12,633	146 Added 14.99%	1,120 $92,000
Q4 2017 Feb 09, 2018	BUY	$52.12 - $72.33 $50,764 - $70,449	974	974 $56,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$336 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$329 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$289 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$222 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$168 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.26B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account